Source: Benzinga

Boston Scientific: Price Over Earnings Overview: Boston Scientific

Looking into the current session, Boston Scientific Inc. (NYSE:BSX) shares are trading at $96.89, after a 3.16% drop. Over the past month, the stock fell by 1.95%, but over the past year, it actually spiked by 44.16%. With questionable short-term performance like this, and great long-term performance, long-term shareholders might want to start looking into the company's price-to-earnings ratio.Boston Scientific P/E Compared to CompetitorsThe P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data ...Full story available on Benzinga.com

Read full article »
Annual Revenue
$10-50B
Employees
50-100K
Michael F. Mahoney's photo - Chairman & CEO of Boston Scientific

Chairman & CEO

Michael F. Mahoney

CEO Approval Rating

75/100

Read more